Lifebit CEO, Dr. Maria Dunford, Accompanies Greek Prime Minister on Trade Visit to India
LONDON, 27 February 2024 Dr. Maria Dunford, CEO of Lifebit, has been selected as one of 10 Greek tech entrepreneurs to accompany […]
Lifebit Empowers Pharma Industry with Unprecedented Access to Multi-Omic and Health Data from Over 100 Million Patients Worldwide
LONDON, 26 February 2024 Global biotechnology leader, Lifebit, achieves a groundbreaking milestone, unlocking the potential of diverse data to accelerate pharmaceutical research […]
Lifebit announces expansion into Asia Pacific and Japan
Lifebit opens R&D centre in Singapore to advance collaboration with Synapxe and Singapore’s public healthcare sector for precision medicine research in Asia […]
Four key benefits of using patient registries to progress rare disease insights
Rare diseases impact between approximately 250-450 million people globally, but they often receive less attention and funding than more common diseases. This can […]
Creating research-ready data from 135,000 cancer, rare disease & COVID-19 participants
Introduction Around the world, organisations across the healthcare system produce huge quantities of information about patients, diseases, and treatments. Highly sensitive and […]
Celebrating International Day of Women and Girls in Science
On February 11th, we celebrate the International Day of Women and Girls in Science, a global initiative recognising women’s pivotal contributions to […]
Health data analysis platforms for all: empowering novice and advanced users for maximum insights
Introduction to health data analysis Healthcare is one of the most data-rich industries and the creation of large datasets is becoming increasingly […]
New webinar series helps researchers get results from data
This week Lifebit is launching a new webinar training series for researchers to learn how Lifebit’s solutions can transform research, accelerate results […]
What’s limiting AI in transforming research and drug discovery? And how can we solve these problems?
Introduction to health data, drug discovery and AI Healthcare is one of the most data-rich industries. This health data is increasingly used […]
Leveraging AI for target validation in drug discovery
Introduction to health data, drug discovery and AI Healthcare is one of the most data-rich industries and the creation of large datasets […]
The four key requirements of patient registry software
Introduction to patient registry software Patient registries are databases that collect and store information about individuals with a particular illness or condition. […]
Challenges facing patient registries in the US
Introduction to patient registries Patient registries are databases that collect and store information about patients with a particular disease or condition. Research […]